Issue 67 July - August 2015

Recognising and reducing the risk of chemotherapy extravasation

When chemotherapy drugs leak from the veins it can cause serious injury to the patient, greatly heighten their fears of undergoing future treatment cycles, and undermine their trust in their medical team. Knowing how to assess and reduce the risks, and what to do when things go wrong, is essential.

Read More ...
Issue 67 July - August 2015

Cancer Core Europe

Can deep and close-knit collaboration between a handful of elite centres achieve what broader European research platforms and projects cannot?

Read More ...
Issue 67 July - August 2015

Medical tourism: a passport to timely high-quality care?

For many patients seeking access to treatments unavailable in their home country, the Cross-border Healthcare Directive turned out to be a bit of a disappointment. But a closer look shows it may help raise standards of care in ways that were not widely anticipated.

Read More ...
Issue 67 July - August 2015

The vitamin D question: whatÂ’s the best advice?

The beta-carotene fiasco warned oncologists off suggesting supplements on the basis of observational studies. But with vitamin D now in the spotlight, how should doctors respond when their patients ask if it could help?

Read More ...
Issue 67 July - August 2015

Frederic Amant: building the evidence base for saving mother and child

Understanding the impact of treating the mother on the long-term health of her unborn child has long been held back by logistical and ethical obstacles to researching this rare patient population. Frédéric Amant took up the challenge.

Read More ...